Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients
Clinical trial NCT01002248 · TERMINATED
Trial details
- NCT number
- NCT01002248
- Sponsor
- AEterna Zentaris
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2013-03-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.